| 专利名称 | USE OF NARINGENIN AND NARINGIN AS INHIBITORS FOR TRANSFORMING GROWTH FACTOR-beta1 SIGNALING PATHWAY | 申请号 | EP20080772950 | 专利类型 | EP | 公开（公告）号 | EP2163247(B1) | 公开（授权）日 | 2014.08.20 | 申请（专利权）人 | 中国科学院生物物理研究所 | 发明（设计）人 | LIANG, WEI;DU, GANGJUN;ZHANG, HONGYAN;JIN, LINGTAO;LV, HEPING;WANG, WEI;LIU, JINPING;JIAO, GUOHUA | 主分类号 | A61K31/352 | IPC主分类号 | A61K31/352;A61K31/7048;A61P1/16;A61P11/00;A61P35/00;A61P35/04;A61P43/00 | 专利有效期 | USE OF NARINGENIN AND NARINGIN AS INHIBITORS FOR TRANSFORMING GROWTH FACTOR-beta1 SIGNALING PATHWAY 至USE OF NARINGENIN AND NARINGIN AS INHIBITORS FOR TRANSFORMING GROWTH FACTOR-beta1 SIGNALING PATHWAY | 法律状态 | 说明书摘要 |
The present invention discloses the use of naringenin and naringin as inhibitors for transforming growth factor-?1 signaling pathway, especially the use of naringenin and naringin as inhibitors for transforming growth factor-?1 signaling pathway in the manufacture of medicaments for treating or preventing fibrosis and cancers. |
1、源头对接，价格透明
2、平台验证，实名审核
3、合同监控，代办手续
4、专员跟进，交易保障